Literature DB >> 26090587

Estrogen and breast cancer: can less mean more?

Marc D Bullock1, Andreia M Silva, George A Calin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26090587      PMCID： PMC5242311          DOI： 10.1080/15384101.2015.1056617

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Authors:  Milena S Nicoloso; Hao Sun; Riccardo Spizzo; Hyunsoo Kim; Priyankara Wickramasinghe; Masayoshi Shimizu; Sylwia E Wojcik; Jana Ferdin; Tanja Kunej; Lianchun Xiao; Siranoush Manoukian; Giorgio Secreto; Fernando Ravagnani; Xuemei Wang; Paolo Radice; Carlo M Croce; Ramana V Davuluri; George A Calin
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis.

Authors:  Trupti Paranjape; Helen Heneghan; Robert Lindner; Florence K Keane; Aaron Hoffman; Antoinette Hollestelle; Jemima Dorairaj; Kimberly Geyda; Cory Pelletier; Sunitha Nallur; John Wm Martens; Maartje J Hooning; Michael Kerin; Daniel Zelterman; Yong Zhu; David Tuck; Lyndsay Harris; Nicola Miller; Frank Slack; Joanne Weidhaas
Journal:  Lancet Oncol       Date:  2011-03-22       Impact factor: 41.316

3.  KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Authors:  Astrid Lièvre; Jean-Baptiste Bachet; Delphine Le Corre; Valérie Boige; Bruno Landi; Jean-François Emile; Jean-François Côté; Gorana Tomasic; Christophe Penna; Michel Ducreux; Philippe Rougier; Frédérique Penault-Llorca; Pierre Laurent-Puig
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

4.  Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.

Authors:  Garnet L Anderson; Marian Limacher; Annlouise R Assaf; Tamsen Bassford; Shirley A A Beresford; Henry Black; Denise Bonds; Robert Brunner; Robert Brzyski; Bette Caan; Rowan Chlebowski; David Curb; Margery Gass; Jennifer Hays; Gerardo Heiss; Susan Hendrix; Barbara V Howard; Judith Hsia; Allan Hubbell; Rebecca Jackson; Karen C Johnson; Howard Judd; Jane Morley Kotchen; Lewis Kuller; Andrea Z LaCroix; Dorothy Lane; Robert D Langer; Norman Lasser; Cora E Lewis; JoAnn Manson; Karen Margolis; Judith Ockene; Mary Jo O'Sullivan; Lawrence Phillips; Ross L Prentice; Cheryl Ritenbaugh; John Robbins; Jacques E Rossouw; Gloria Sarto; Marcia L Stefanick; Linda Van Horn; Jean Wactawski-Wende; Robert Wallace; Sylvia Wassertheil-Smoller
Journal:  JAMA       Date:  2004-04-14       Impact factor: 56.272

5.  Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.

Authors:  Terri P McVeigh; Song-Yi Jung; Michael J Kerin; David W Salzman; Sunitha Nallur; Antonio A Nemec; Michelle Dookwah; Jackie Sadofsky; Trupti Paranjape; Olivia Kelly; Elcie Chan; Nicola Miller; Karl J Sweeney; Daniel Zelterman; Joann Sweasy; Robert Pilarski; Donatello Telesca; Frank J Slack; Joanne B Weidhaas
Journal:  Cell Cycle       Date:  2015-05-11       Impact factor: 4.534

Review 6.  MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Authors:  Monica Cipollini; Stefano Landi; Federica Gemignani
Journal:  Pharmgenomics Pers Med       Date:  2014-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.